ClinVar Miner

Submissions for variant NM_000391.4(TPP1):c.1402A>C (p.Ile468Leu)

dbSNP: rs796053443
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000189792 SCV000243440 uncertain significance not provided 2012-10-03 criteria provided, single submitter clinical testing p.Ile468Leu (ATT>CTT):c.1402 A>C in exon 11 of the TPP1 gene (NM_000391.3)The Ile468Leu missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Project has not identified Ile468Leu in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is conservative, as both Isoleucine and Leucine are uncharged, non-polar amino acid residues. However, Ile468Leu alters a position in the tripeptidyl-peptidase 1 (TPP-1) protein that is well conserved in mammals. Several in silico models predict that Ile468Leu is benign, although one model indicates it may be damaging to protein structure/function. Therefore, based on the currently available information, it is unclear whether Ile468Leu is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.